ada.enesco, Author at European Medical Journal - Page 14 of 65

Common Cold May Prime Children’s Defences Against COVID-19

A new study suggests that the common cold may boost children’s antiviral defences, lowering the risk and severity of COVID-19.

ESC 2025: Raising Potassium Reduces Ventricular Arrhythmia Risk in High-Risk Patients

The POTCAST trial shows raising plasma potassium to high-normal levels reduces ventricular arrhythmia risk, hospitalisations, and death in ICD patients.

New Treatment Shows Promise for Reducing Acne Scars

Objective biometric measures showed improvement in both groups, but the combination therapy produced significantly greater benefits.

ESC 2025: Digitoxin Trial Redefines Role of Glycosides in Heart Failure

DIGIT-HF shows digitoxin reduces death and hospitalisation in advanced heart failure, offering an additional option for high-risk patients on top of standard therapy.

ESC 2025: Age Drives Arrhythmia Risk While Fitness Offers Protection

A large study finds age strongly increases arrhythmia risk, while higher fitness levels protect against atrial ectopy in asymptomatic adults.

Airway Bacteria Show Protective Effect in Pneumonia and Flu

Airway bacteria like Streptococcus oralis may boost natural immune defences, helping protect against pneumonia and viral infections, new research suggests.

ESC 2025: CPR Devices Put to the Test in Zero Gravity

Automatic chest compression devices outperform manual methods for CPR in simulated zero gravity, with piston devices meeting guideline-recommended standards.

ESC 2025: Ethnic Differences Shape Cardiovascular Outcomes in Hypertension

A major analysis finds Afro-American patients with hypertension face higher cardiovascular morbidity, while Asian patients carry a greater risk of stroke.

Flu and COVID-19 May Awaken Dormant Breast Cancer Cells

Respiratory viruses such as influenza and SARS-CoV-2 can awaken dormant breast cancer cells, driving metastasis and raising mortality risk in cancer survivors, new research finds.

Nonviral Gene Therapy Shows Promise for Age-Related Heart Disease

Nonviral gene therapy to boost brown fat molecule reverses age-related heart dysfunction in animal studies.